242 related articles for article (PubMed ID: 21170718)
1. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process.
Sen T; Chatterjee A
Eur J Nutr; 2011 Sep; 50(6):465-78. PubMed ID: 21170718
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
Sen T; Dutta A; Chatterjee A
Anticancer Drugs; 2010 Jul; 21(6):632-44. PubMed ID: 20527725
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.
Sen T; Moulik S; Dutta A; Choudhury PR; Banerji A; Das S; Roy M; Chatterjee A
Life Sci; 2009 Feb; 84(7-8):194-204. PubMed ID: 19105967
[TBL] [Abstract][Full Text] [Related]
4. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
Maity G; Choudhury PR; Sen T; Ganguly KK; Sil H; Chatterjee A
Tumour Biol; 2011 Feb; 32(1):129-38. PubMed ID: 20821288
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
6. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
8. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
Thangapazham RL; Passi N; Maheshwari RK
Cancer Biol Ther; 2007 Dec; 6(12):1938-43. PubMed ID: 18059161
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E
Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Li YF; Wang H; Fan Y; Shi HJ; Wang QM; Chen BR; Khurwolah MR; Long QQ; Wang SB; Wang ZM; Wang LS
Cell Physiol Biochem; 2017; 43(3):926-936. PubMed ID: 28957799
[TBL] [Abstract][Full Text] [Related]
11. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Park JH; Cho YY; Yoon SW; Park B
Int J Oncol; 2016 Sep; 49(3):1230-40. PubMed ID: 27573547
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
[TBL] [Abstract][Full Text] [Related]
13. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase 1: A target in the capacity of dimeric ECG and EGCG procyanidins to inhibit colorectal cancer cell invasion.
Zhu W; Oteiza PI
Redox Biol; 2023 Sep; 65():102827. PubMed ID: 37516013
[TBL] [Abstract][Full Text] [Related]
15. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
Liang YC; Chen YC; Lin YL; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 1999 Apr; 20(4):733-6. PubMed ID: 10223207
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of MDA-MB-231 can be suppressed by dimeric-epigallocatechin gallate through competitive inhibition of amphiregulin-epidermal growth factor receptor signaling.
Huang Y; Zhang X; Pang Q; Zhu Q; Liang Q; Zi C; Zhang D; Xiang Z; Wang X; Sheng J
Anticancer Drugs; 2021 Jun; 32(6):647-656. PubMed ID: 33587351
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
20. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Vayalil PK; Katiyar SK
Prostate; 2004 Apr; 59(1):33-42. PubMed ID: 14991864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
